[HTML][HTML] Immune determinants of Barrett's progression to esophageal adenocarcinoma

KH Lagisetty, DP McEwen, DJ Nancarrow… - JCI insight, 2021 - ncbi.nlm.nih.gov
Esophageal adenocarcinoma (EAC) develops from Barrett's esophagus (BE), a chronic
inflammatory state that can progress through a series of transformative dysplastic states …

[HTML][HTML] Targeting myeloid-derived suppressor cells for cancer therapy

H Tang, H Li, Z Sun - Cancer biology & medicine, 2021 - ncbi.nlm.nih.gov
The emergence and clinical application of immunotherapy is considered a promising
breakthrough in cancer treatment. According to the literature, immune checkpoint blockade …

The tumour immune microenvironment in oesophageal cancer

M Davern, NE Donlon, R Power, C Hayes… - British Journal of …, 2021 - nature.com
Oesophageal cancer (OC) is an inflammation-associated malignancy linked to gastro-
oesophageal reflux disease, obesity and tobacco use. Knowledge of the microenvironment …

[HTML][HTML] CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients

TA Karakasheva, GA Dominguez, A Hashimoto… - JCI insight, 2018 - ncbi.nlm.nih.gov
BACKGROUND. Myeloid-derived suppressor cells (MDSCs) are a population of immature
immune cells with several protumorigenic functions. CD38 is a transmembrane receptor …

A polysaccharide from native Curcuma kwangsiensis and its mechanism of reversing MDSC-induced suppressive function

S Jiang, J Ma, Y Li, B Lu, J Du, J Xu, Z Qin, T Ning… - Carbohydrate …, 2022 - Elsevier
A purified polysaccharide nCKAP-2 was prepared from Curcuma kwangsiensis and
characterized. Structural analyses revealed that nCKAP-2 contains a high-branched …

The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy

D Wang, G An, S Xie, Y Yao, G Feng - Tumor Biology, 2016 - Springer
Myeloid-derived suppressor cells (MDSCs) are key player in mediating systemic
immunosuppression, and their accumulation and expansion in the periphery and tumor …

Immunomodulatory roles of nitric oxide in cancer: Tumor microenvironment says “NO” to antitumor immune response

J PeÑarando, E Aranda, A RodrÍguez-Ariza - Translational Research, 2019 - Elsevier
In recent years, an increasing number of studies have shown that there is an important
connection between nitric oxide (NO) and the pathology of malignant diseases, but we are …

High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients

N Elwan, ML Salem, A Kobtan, F El-Kalla… - Immunological …, 2018 - Taylor & Francis
Background: Hepatocellular carcinoma (HCC) is the 3rd most common cause of cancer-
related death worldwide. It has evolved different immune escape mechanisms, which might …

Trial Watch: Toll-like receptor agonists in oncological indications

F Aranda, E Vacchelli, F Obrist, A Eggermont… - …, 2014 - Taylor & Francis
Toll-like receptors (TLRs) are an evolutionarily conserved group of enzymatically inactive,
single membrane-spanning proteins that recognize a wide panel of exogenous and …

Neutrophils: new critical regulators of glioma

G Wang, J Wang, C Niu, Y Zhao, P Wu - Frontiers in Immunology, 2022 - frontiersin.org
In cancer, neutrophils are an important part of the tumour microenvironment (TME). Previous
studies have shown that circulating and infiltrating neutrophils are associated with malignant …